FILING ANALYSIS · MONDAY, NOVEMBER 2
IDEXX LABORATORIES INC /DE IDXX — 8-K: Results of Operations and Financial Condition
positive
IDEXX Laboratories reported strong third quarter results with 10% revenue growth and 18% EPS growth, driven by double-digit organic revenue growth in CAG Diagnostics, and raised its 2026 revenue and EPS guidance, indicating a positive outlook for the company.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →